Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
12/2008
12/04/2008US20080300238 Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic
12/04/2008US20080300230 Use of extracts of the genus cimicifuga as organoselective medicines for treating diseases of the genitourinary tract caused by sex hormones
12/04/2008US20080300224 Treatment of conditions relating to hormone deficiencies by administration of progestins
12/04/2008US20080299134 Recombinant Anti-Interleukin-9 Antibodies
12/04/2008DE102007025107A1 Arzneimittel zur Behandlung von Fertilitäts- und Schwangerschaftsstörungen und immunologisch-bedingten Erkrankungen und Transplantationen zur Anwendung in der Tiermedizin, insbesondere bei Pferden sowie Verfahren zur Herstellung Medicines used to treat fertility and pregnancy disorders and immunologically-related disorders and transplantation for use in veterinary medicine, particularly in horses and methods of making
12/04/2008CA2688394A1 Novel compounds and pharmaceutical preparations
12/03/2008EP1997512A2 Methods for treating TWEAK-related conditions
12/03/2008EP1997498A2 Krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases, arthritis, skin cancer, diabetes, premenstrual syndrome and transdermal transport
12/03/2008EP1997494A2 Modulators of hedgehog signaling pathways, compositions and uses related thereto
12/03/2008EP1997492A1 Method of treatment
12/03/2008EP1996571A2 Tetracyclic steroid derivatives useful as progesterone receptor modulators
12/03/2008EP1996209A1 Contraceptive composition
12/03/2008EP1492785B1 2-hydroxy-3-heteroarylindole derivatives as gsk3 inhibitors
12/03/2008EP1480954B1 Vanilloid receptor modulators
12/03/2008EP1478366B1 Pharmaceutical combinations of meloxicam, codeine phosphate and paracetamol
12/03/2008CN101316857A Prodrug ER-beta-selective substances, methods for the production thereof and pharmaceutical compositions containing said compounds
12/03/2008CN101316595A Formulations with improved bioavailability, comprising a steroid derivative and a polyglycolysed glyceride
12/03/2008CN101314020A Preparation method for Chinese medicine for treating acyesis
12/03/2008CN101314010A Liquefied clearing pill
12/03/2008CN101313974A Chinese potato capsule
12/03/2008CN101313973A Cockscomb flower effervescent tablet beverage
12/03/2008CN101313951A Traditional chinese medicine for activating blood circulation and removing stasis to treat gynaecologic diseases
12/03/2008CN101313926A Transcription regulating and controlling article composition
12/03/2008CN101313920A Application of truffle extract in preparing foods, medicine for treating endocrine dyscrasia diseases
12/03/2008CN101313904A Fenticonazole suppository for treating exterior colpitis
12/03/2008CN100439366C Pyrido[2,3-d]pyrimidine-2,4-diamines as PDE2 inhibitors
12/03/2008CN100439340C 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
12/03/2008CN100438905C Stable liquid formulations of botulinum toxin
12/03/2008CN100438903C Quality control method of fuyuekang Chinese medicinal preparation
12/03/2008CN100438858C Preparation method of Chinese clinopodium herb effervescence tablet
12/02/2008US7459470 For example, N-(Isoquinolin-3-yl)-2-(4-pyridylmethyl)aminobenzoic acid amide-N-oxide; use as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis, such as psoriasis, arthritis, hemangioma, angiofibroma, eye diseases, cirrhosis of the liver
12/02/2008US7459293 Polypeptide of given sequence; stimulating immune system and proliferation or development of hematopoietic cells
12/02/2008CA2492417C Formulation for menopausal women
12/02/2008CA2352552C Treatment of erectile dysfunction
12/02/2008CA2267671C Method for manufacturing expanded hematopoietic cells with stem cell factor polypeptide
12/02/2008CA2182062C Substituted cinnamic acid guanidides, a process for their preparation, their use as medicaments or diagnostic agents, and medicaments comprising them
11/2008
11/27/2008WO2008144473A2 Chimeric pufa polyketide synthase systems and uses thereof
11/27/2008WO2008144305A1 Diaryl-substituted tetrahydroisoquinolines as histamine h3 receptor and serotonin transporter modulators
11/27/2008WO2008142319A2 Peptide analogues of melanocortin receptors
11/27/2008WO2008141570A1 A composition for improving quality of fetus, preventing and treating birth defects
11/27/2008WO2008116825A3 Compositions and method for treating pediatric hypogonadism
11/27/2008WO2008083192A3 Methods and formulations for improved bioavailability of antiprogestins
11/27/2008US20080293797 Central nervous system disorders; respiratory system disorders; sexual or reproductive disorders; eating disorders; antidiabetic agents; cardiovascular disorders; anticancer agents
11/27/2008US20080293658 Antisense oligonucleotides capable of inhibiting the formation of capillary tubes by endothelial cells
11/27/2008US20080293622 Methods of inducing ovulation
11/27/2008US20080293163 Methods to identify compounds that modulate rage
11/27/2008US20080293116 Ovary-specific genes and proteins
11/27/2008US20080292544 Modified Proteins, Designer Toxins, and Methods of Making Thereof
11/27/2008DE102007023614A1 New amide compounds used for treatment of gynecological diseases e.g. endometriosis, for female fertility control and female hormone replacement therapy, has general formula
11/27/2008CA2687523A1 Chimeric pufa polyketide synthase systems and uses thereof
11/26/2008EP1995238A2 Novel tetrahydrocarbazole derivatives with improved biological action and improved solubility as ligands for g-protein coupled receptors (GPCRS)
11/26/2008EP1994936A1 Lactobacilli for the prevention of mastitis and for reducing the risk of allergy in breast-fed infants
11/26/2008EP1993556A1 An improved method of weaning from hormonal treatment of hormone depletion induced vasomotor symptoms
11/26/2008EP1993531A2 Extended cycle multiphasic oral contraceptive method
11/26/2008EP1534707B9 Substituted 2,4-dihydro-pyrrolo (3, 4-b) -quinolin-9-one derivatives useful as phosphodiesterase inhibitors
11/26/2008EP1330452B1 Pyrazine derivatives as modulators of tyrosine kinases
11/26/2008CN101312946A 9-chloro-15-deoxyprostaglandin derivatives, process for their preparation and their use as medicaments
11/26/2008CN101312733A Use of estradiol valerate or estradiol combined with dienogest for the oral therapy of dysfunctional uterine bleeding in the form of oral contraceptives
11/26/2008CN101311273A Biosynthesis gamma-aminobutyric acid preparation and method for preparing same
11/26/2008CN101310759A Biogenic source sex hormone starting replenisher
11/26/2008CN101310744A Purification enrichment method of Guangdong purple beautyberry total flavone part
11/26/2008CN101310739A Cassia Tuckahoe composition and preparation method thereof
11/26/2008CN101310734A Chinese and western combine compound uterus perfusate for treating cow endometritis
11/26/2008CN100436452C Pyrazole compounds useful as protein kinase inhibitors
11/26/2008CN100436439C Dimeric isoflavones
11/26/2008CN100435841C Medicament for treating phlebitis of mammary gland
11/26/2008CN100435837C Medicine and food dual purpose Chinese medicine for preventing and treating premature ejaculation and seminal emission and its manufacturing method
11/26/2008CN100435836C Medicine and food dual purpose Chinese medicine for preventing and treating impotence and premature ejaculation and its manufacturing method
11/26/2008CN100435835C Medicine and food dual purpose Chinese medicinal health care product for preventing ane treating emission and its manufacturing method
11/26/2008CN100435834C Chinese medicinal preparation for treating sterility, its preparation and quality control method
11/26/2008CN100435787C Preventive or remedy for intrauterine late embryonic development or pregnancy toxemia
11/25/2008US7456253 Growth hormone releasing peptides
11/25/2008US7456201 Such as N-{5-[1-(4-tert-butylphenyl)-3-pyridin-2-yl-1H-pyrazol-5-yl]pentanoyl}tyrosinamide; useful for the treatment of mammalian infertility
11/25/2008US7456170 Triazolobenzodiazepines and their use as vasopressin antagonists
11/25/2008US7456168 2-(pyridin-2-ylamino)-pyrido[2,3, d]pyrimidin-7-ones
11/25/2008US7456160 Sustained release; injection of fulvestrant; using 7 alpha -[9-(4,4,5,5,5-pentafluoropentylsulphinyl)nonyl]oestra-1,3,5(10)-triene-3,17 beta -diol to treat hormonal dependent benign or malignant disease of the breast or reproductive tract
11/25/2008US7455839 Method of inhibiting the formation of inhibin/betaglycan complexes with an anti-betaglycan antibody
11/25/2008CA2376791C Drug delivery device for insertion in the vagina, rectum or nasal cavity
11/25/2008CA2342830C 5-heterocyclyl pyrazolo[4,3-d]pyrimidin-7-ones for the treatment of male erectile dysfunction
11/25/2008CA2256977C Methods of extended use oral contraception
11/20/2008WO2008139845A1 Novel amide derivative
11/20/2008WO2008139202A1 Neutralizing monoclonal antibody against human dll4
11/20/2008WO2008070313A3 3-(dihydro-1h-pyrazolo [4,3-d] pyrimidin-5-yl)-4-propoxybenzenesulfonamide derivatives and methods of use
11/20/2008US20080287549 Methods and materials for controlling rodent populations
11/20/2008US20080287539 Use of carnitines for the prevention and/or treatment of disorders caused by the andropause
11/20/2008US20080287495 Novel benzo[d][1,3]-dioxol derivatives
11/20/2008US20080287493 Arylmethylen substituted n-acyl-y-aminoalcohols
11/20/2008US20080287444 Pyrazole compounds useful as protein kinase inhibitors
11/20/2008US20080287408 Endometriosis treatment
11/20/2008US20080287390 Pyrazolidinol compounds
11/20/2008US20080286386 Enzyme inhibitors; gene expression inhibition
11/20/2008US20080286382 Selenium, selenized yeast; gene expression inhibition
11/20/2008US20080286296 Cyclic-Dinucleotides and Its Conjugates as Adjuvants and Their Uses in Pharmaceutical Compositions
11/20/2008US20080286288 Vascular endothelial growth factor 2
11/19/2008EP1991224A2 Use of piperacillin in topical intravaginal preparations for the treatment of vaginal bacterial infections
11/19/2008EP1991218A1 Use of cyclolignans for the treatment of type 2 diabetes and as contraceptives
11/19/2008EP1791863A4 Truncated lhrh formulations
11/19/2008EP1272169B1 Use of 13-hode as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia
11/19/2008EP1268775B1 The high bone mass gene of 11q13.3
11/19/2008CN101307279A Nourishing cordial and method for preparing same